Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course corticosteroid added to H1 antihistamines in acute urticaria: randomized double-blind controlled trial
TCTR20180321001Phase 4Recruiting
- Sponsor
- Rachada
- Start
- Sep 2017
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in urticaria and allergy (2 arms), sponsored by Rachada. Started Sep 2017; status: recruiting.
02
Conditions
urticariaallergy
Beyond the preview
Go deeper on TCTR20180321001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180321001.